If you’ve been researching mycotoxin testing for your home or workplace, there’s a good chance the EMMA test has come up. Offered by RealTime Labs, the EMMA (Environmental Mold and Mycotoxin Assessment) test has long been the go-to option for testing mycotoxins in indoor environments — not because it was the best available method, but because until recently, it was the only one. With no airborne alternative on the market, dust-based testing became the default, making EMMA the standard choice for functional medicine practitioners and environmental professionals alike.
But before you order any test, it’s worth understanding exactly what it measures, how it works, and what questions it can — and cannot — answer. This guide walks through the EMMA test methodology honestly, explains the science behind dust-based testing, and introduces a key question you should ask before choosing any mycotoxin test: Are you testing historical contamination, or what you’re actively breathing?
Start With the Right Question
Before choosing any mycotoxin test, clarify what you want to know: past contamination, or current inhalation exposure.
What Is the EMMA Test?
The EMMA test (Environmental Mold and Mycotoxin Assessment) is a laboratory test offered by RealTime Labs, a Texas-based laboratory. It is designed to detect the presence of mold and mycotoxins in indoor environments by analyzing a sample of settled dust collected from the home.
The test screens for multiple species of mold and a broad panel of mycotoxins, including trichothecenes, ochratoxin, aflatoxins, gliotoxin, and others. The dust sample is typically collected using a specialized collection kit, often from a furnace filter, window sill, or other surface where household dust accumulates, and mailed to the lab for analysis.
The EMMA test uses two distinct analytical methods: MSQPCR (mold-specific quantitative polymerase chain reaction) to detect and quantify fungal DNA for mold species identification, and ELISA (enzyme-linked immunosorbent assay) for mycotoxin detection. Results are returned as a report showing which mold species and mycotoxins were detected in the collected dust.
How Dust-Based Mycotoxin Testing Works
To understand what the EMMA test is measuring, you first need to understand the medium it samples: settled dust.
Indoor dust is not a snapshot of your current environment. It is an accumulation of particles that were once airborne and have since fallen out of the air and settled onto surfaces. Dust in a home builds up from particles that settle out of the air over time. It reflects what has been in the air in the past, not necessarily what you are breathing right now.
When a dust sample is analyzed for mycotoxins, the lab is detecting compounds that were deposited into that dust reservoir over an extended period. The detection of a mycotoxin in settled dust confirms that the compound has been present in the home’s environment at some point, but it does not tell you whether that compound is currently suspended in the air you are breathing.
This distinction is the foundation of what environmental scientists call analytical domain non-equivalence, a principle formalized in a series of 2026 scientific preprints published by Respirare Labs (Ritacco 2026a; Ritacco 2026b). Each type of environmental measurement (airborne, dust, and surface) operates within a distinct analytical domain governed by different physical properties and time windows. Results from one domain cannot be assumed to represent conditions in another.
What Dust Testing Can Tell You, and What It Can't
Dust-based testing like the EMMA test provides genuinely useful information, but it is important to understand the scope of what that information represents.
Scope Defines Meaning
Dust testing confirms historical presence. It does not confirm current airborne exposure. What a method measures determines what its results mean.
Post-remediation verification is where the choice of testing method matters most. When someone hires a remediation company, they are often spending thousands of dollars to make their home safer. It is completely reasonable to want proof that the work actually reduced airborne exposure.
What dust testing can tell you:
- Whether specific mycotoxins have been present in your home’s environment over time
- Whether mold species capable of producing mycotoxins have historically been active in the space
- Whether there is a record of contamination in settled surface reservoirs
What dust testing cannot tell you:
- Whether mycotoxins are currently circulating in the air you are breathing right now
- Whether your current inhalation exposure is elevated
- Whether mycotoxins detected in dust are actively reaching your respiratory tract
This last point is supported by established indoor aerosol science. Once particles settle from air into a dust reservoir, they have undergone a phase transition: they have moved from the dynamic airborne environment into a static, surface-bound state. The presence of a compound in settled dust does not, on its own, establish whether that compound is currently present or at what concentration in the breathing-zone aerosol at the time of sampling (Ritacco 2026b; Nazaroff, 2014).
In plain terms: you can have detectable mycotoxins in your dust without a meaningful airborne exposure, and you can have an elevated airborne mycotoxin environment that hasn’t yet deposited heavily into measurable dust levels.
Historical Presence ≠ Current Exposure
A positive dust result confirms past presence. It does not confirm what is circulating in your breathing zone today.
Consider What You're Actually Being Asked to Sample
Before interpreting EMMA results, it’s worth pausing on something most people overlook: where the dust actually comes from.
RealTime Labs’ own sampling instructions suggest collecting dust from places like the back of your refrigerator, under furniture, or from an unused swiffer duster. These locations are recommended precisely because dust accumulates there undisturbed, which is exactly the point. The older and more settled the dust, the more material there is to test.
But think about what that means for interpretation. Dust behind a refrigerator may represent years of accumulation. It hasn’t been disturbed, cleaned, or circulated in any meaningful way. It is about as disconnected from your current breathing environment as a sample could be. Drawing a conclusion about your active mycotoxin exposure from that material is a significant inferential leap, and one that the sample itself cannot support.
This isn’t a criticism of the lab. It’s a limitation that is baked into the methodology. When your test medium is settled dust, you are by definition working with historical data. The sampling instructions simply make that reality more visible than most people realize when they order the test.
Contrast that with airborne breathing-zone sampling, where the sample is collected from the air at the height and location where you actually breathe, during the time period being assessed. There is no inferential gap between what was sampled and what you inhaled. The sample is your breathing environment.
Sample Location Shapes Meaning
Dust collected from undisturbed areas may represent years of accumulation. That does not automatically reflect your current breathing environment.
The EMMA Test Combines Two Measurements That Don't Always Agree
Most people don’t realize the EMMA test combines two completely different types of measurements into a single report. Understanding what each one is actually detecting changes how you interpret your results.
The EMMA test uses MSQPCR to detect fungal DNA in dust, which is a biological indicator. It tells you that certain mold organisms (or their genetic material) have been present. It also uses ELISA to detect mycotoxin compounds, which are chemical indicators.
These are not interchangeable. According to the analytical framework established in the Respirare Labs preprint series (Ritacco 2026a), biological indicators like mold spore counts and fungal DNA primarily characterize organism presence and dispersal. Chemical indicators, including mycotoxins, are secondary metabolites that behave according to very different physical rules once released into the environment.
Critically, mycotoxins can persist in indoor environments long after active mold growth has ceased. They are chemically stable, low-volatility compounds that can associate with fine and ultrafine aerosol particles, or accumulate in settled dust, independent of ongoing fungal activity. This means that the detection of fungal DNA in dust does not guarantee that mycotoxins are concurrently present in the air, and vice versa.
The Question You Should Be Asking: What Are You Being Exposed To and What Are You Actually Inhaling?
Indoors, mycotoxins most often reach people through the air they breathe. If your concern is what may be reaching your lungs, the most relevant place to look is the air in your breathing zone right now.
Inhalation Is an Air Question
If exposure occurs through breathing, the measurement must come from the air — not from settled reservoirs.
Mycotoxins travel through indoor air attached to particles. Specifically, research indicates they tend to associate with fine and ultrafine particles (particles smaller than 2.5 micrometers) that remain airborne for extended periods due to their aerodynamic properties. These are the same particle fractions that penetrate deepest into the respiratory tract, reaching the lower bronchi and even the alveolar region of the lungs. They dominate indoor particle number concentrations but contribute minimally to total particulate mass, which is why mass-based sampling methods often miss them (Ritacco 2026a).
The distinction becomes significant: spore traps and dust-based methods primarily capture coarse particles, larger biological structures that settle relatively quickly. The fine and ultrafine particles carrying mycotoxins behave completely differently. They stay airborne longer, move through low-ventilated spaces, and reach deeper into the lungs.
This is the scientific case for airborne breathing-zone sampling as the domain-aligned approach for inhalation exposure questions. When you sample directly from the breathing-zone air, you get a real-time measurement of what is actually present in the air at the time of sampling, rather than a record of what has accumulated over time (Ritacco 2026c). For a practical breakdown of how airborne mycotoxin results should be interpreted in this context, see our Airborne Mycotoxins Exposure Interpretive Guide.
Understanding Inhalation-Aligned Airborne Testing
Inhalation-aligned airborne mycotoxin testing, the methodology underlying Respirare Labs’ AMEA™ (Airborne Mycotoxin Environmental Analysis), works differently from dust-based testing in one fundamental way: it samples directly from the air in your breathing zone, capturing the particle fraction you actually inhale.
Using an IOM (Institute of Occupational Medicine) sampler positioned at breathing-zone height, air is drawn through the sampler over a defined interval at a calibrated flow rate. The collected particles are then analyzed using established analytical chemistry methods. Because the sample is collected from suspended particles in real time, rather than from material that has already settled, it reflects what is present in your airborne environment under the conditions at the time of sampling.
Aligned With Exposure Science
Breathing-zone sampling follows established occupational hygiene principles and international inhalation standards, measuring the air you actually inhale.
This approach is rooted in occupational hygiene science and aligns with international standards for inhalation exposure assessment (ACGIH, 2022; ISO 7708; EN 481). It treats the inhalation exposure question of “what am I breathing?” as exactly that: an airborne question requiring an airborne answer.
Which Test Might Be Right for Your Situation?
Both dust-based and airborne testing can provide value depending on what question you’re trying to answer. Here’s an honest framework for thinking about it:
A dust-based test like EMMA may be appropriate if you want to:
- Understand whether your home has a history of mold contamination
- Screen for past mycotoxin presence as a baseline assessment
- Complement an environmental investigation with reservoir data
An airborne breathing-zone test like AMEA™ may be more appropriate if you want to:
- Understand what you and your family are currently inhaling
- Assess inhalation exposure in the context of ongoing health symptoms potentially related to mycotoxin exposure
- Verify air quality following mold remediation work
- Answer the specific question your functional medicine doctor is asking about current exposure
The key insight is that these are different questions, answered by different methods. Interpreting a dust measurement as evidence of current inhalation exposure without additional airborne confirmation is a form of what the scientific literature calls cross-domain substitution: extending a measurement beyond the physical and temporal context in which it was collected (Ritacco 2026b).
Dust vs Airborne Mycotoxin Testing: Side-by-Side
| Feature | EMMA (Dust-Based) | AMEA™ (Airborne) |
|---|---|---|
| Sample Medium | Settled household dust | Breathing-zone air |
| Time Frame | Historical accumulation | Real-time snapshot |
| Exposure Alignment | Indirect | Direct inhalation |
| Particle Type Captured | Mostly coarse particles | Fine & ultrafine particles |
| Best For | Contamination history | Current inhalation exposure |
| Remediation Verification | Limited | Strong alignment |
The Bottom Line
The EMMA test is a legitimate and widely used method for detecting mold and mycotoxins that have settled into household dust. If this test has been recommended to you, the laboratory analysis is valid and the results are real for what dust sampling is designed to show. It reflects what has accumulated in the home over time, within the limits of what dust-based testing can tell you.
Before choosing a test, it helps to pause and ask: what question am I actually trying to answer?
If your question is “Has my home had mold or mycotoxin contamination?” a dust test can help with that.
If your question is “Am I currently being exposed to mycotoxins in the air I breathe?” that is an airborne question, and it should be answered with airborne testing.
If you’re trying to understand what you’re actively inhaling, Respirare Labs’ AMEA™ Air Test Kit samples mycotoxins directly from your breathing zone — the air you and your family are actually breathing. It ships to your door, takes minutes to collect, and gives you results grounded in inhalation exposure science. Order your kit today or find a certified provider near you if you’d prefer a professional assessment.
Best Mycotoxin Test for Your Home FAQs
The EMMA test screens for mold species and mycotoxins in a sample of settled household dust. The mold panel identifies specific fungal species using MSQPCR, while the mycotoxin panel detects compounds including trichothecenes, ochratoxin A, aflatoxins, gliotoxin, and zearalenone using ELISA.
The lab methods behind the EMMA test are scientifically valid. The more important question is what the results actually tell you. Because the test samples settled dust — not the air you're breathing — it reflects what has accumulated in your home over time, not necessarily what's currently circulating in your breathing space.
Not directly. Settled dust is a historical record of what has been present in your home over time. A positive result means mycotoxins have been there, but doesn't confirm they're currently airborne. A negative result doesn't guarantee your air is clear either, particularly if conditions have changed recently.
The EMMA test analyzes settled dust collected from surfaces or HVAC filters. Airborne testing like AMEA™ samples particles directly from the air at breathing-zone height in real time. One tells you about your home's history; the other tells you what you're actively inhaling right now.
If your main concern is what you and your family are breathing, the most relevant test is AMEA airborne mycotoxin testing. AMEA measures mycotoxins in breathing-zone air during the sampling period, which directly reflects inhalation exposure. Dust testing, by contrast, shows what has settled and accumulated in the home over time. It can help describe contamination history, but it does not tell you what is in the air right now.
Yes. Dust and air don't always tell the same story. Mycotoxins can be actively circulating in your breathing space without having built up enough in settled dust to trigger a positive result, particularly after a disturbance like cleaning, construction, or HVAC activity. The reverse is also true: old mycotoxins can linger in dust long after the active source has been removed.
References
- Ritacco, M. (2026a). Physicochemical Divergence of Mycotoxin and Biological Indicators Across Airborne, Dust Reservoir, and Surface Analytical Domains in Indoor Environments. Respirare Labs Preprint Archive.
- Ritacco, M. (2026b). An Exposure-Aligned Analytical Domain Framework for Interpreting Mycotoxin Measurements Across Airborne, Dust, and Surface Media in Indoor Environments. Respirare Labs Preprint Archive.
- Ritacco, M. (2026c). Operationalizing the Exposure-Aligned Analytical Domain Framework for Indoor Mycotoxins: Inhalation-Aligned Airborne Assessment in Indoor Environments. Respirare Labs Preprint Archive.
- Nazaroff, W. W. (2014). Indoor particle dynamics. Indoor Air, 24(3), 254–256.
- Bennett, J. W., & Klich, M. (2003). Mycotoxins. Clinical Microbiology Reviews, 16(3), 497–516.
- Morawska, L., & Nazaroff, W. W. (2013). The evolution of indoor particle research. Indoor Air, 23(6), 442–454.
- Hinds, W. C. (1999). Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles (2nd ed.). Wiley.
- Lindemann, L., et al. (2022). Airborne mycotoxins. Annals of Work Exposures and Health, 66(5), 567–580.
- American Conference of Governmental Industrial Hygienists. (2022). TLVs and BEIs.
- International Organization for Standardization. (1995). ISO 7708: Air quality — Particle size fraction definitions for health-related sampling.
- European Committee for Standardization. (1993/2019). EN 481: Workplace atmospheres — Size fraction definitions for measurement of airborne particles.
- RealTime Labs. (n.d.). Buy (EMMA) Environmental Mold and Mycotoxin Test. Retrieved February 2026. (Confirms MSQPCR methodology for EMMA mold detection.)
- RealTime Labs. (n.d.). The Difference Between Mold Spores and Mycotoxins. Retrieved February 2026. (References ELISA for environmental mycotoxin detection in the context of EMMA.)
